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Abstract
Medical tourism is a growing phenomenon with policy implications for health systems, particularly of destination
countries. Private actors and governments in Southeast Asia are promoting the medical tourist industry, but the
potential impact on health systems, particularly in terms of equity in access and availability for local consumers, is
unclear. This article presents a conceptual framework that outlines the policy implications of medical tourism’s
growth for health systems, drawing on the cases of Thailand, Singapore and Malaysia, three regional hubs for
medical tourism, via an extensive review of academic and grey literature. Variables for further analysis of the
potential impact of medical tourism on health systems are also identified. The framework can provide a basis for
empirical, in country studies weighing the benefits and disadvantages of medical tourism for health systems. The
policy implications described are of particular relevance for policymakers and industry practitioners in other
Southeast Asian countries with similar health systems where governments have expressed interest in facilitating
the growth of the medical tourist industry. This article calls for a universal definition of medical tourism and
medical tourists to be enunciated, as well as concerted data collection efforts, to be undertaken prior to any
meaningful empirical analysis of medical tourism’s impact on health systems.
Introduction
Growing demand for health services is a global phenom-
enon, linked to economic development that generates ris-
ing incomes and education. Demographic change,
especially population ageing and older people’s require-
ments for more medical services, coupled with epidemiolo-
gical change, i.e. rising incidence of chronic conditions,
also fuel demand for more and better health services. Wait-
ing times and/or the increasing cost of health services at
home, coupled with the availability of cheaper alternatives
in developing countries, has lead new healthcare consu-
mers, or medical tourists, to seek treatment overseas [1].
The correspondent growth in the global health service sec-
tor reflects this demand. The globalisation of healthcare is
marked by increasing international trade in health products
and services, strikingly via cross border patient flows.
In Southeast Asia, the health sector is expanding
rapidly, attributable to rapid growth of the private sector
and notably, medical tourism, which is emerging as a
lucrative business opportunity. Countries here are capita-
lising on their popularity as tourist destinations by com-
bining high quality medical services at competitive prices
with tourist packages. Some countries are establishing
comparative advantages in service provision based on
their health system’s organizational structure (table 1).
Thailand has established a niche for cosmetic surgery
and sex change operations, whilst Singapore is attracting
patients at the high end of the market for advanced treat-
ments like cardiovascular, neurological surgery and stem
cell therapy [2]. In Singapore, Malaysia and Thailand
alone, an estimated 2 million medical travellers visited in
2006 - 7, earning these countries over US$ 3 billion in
treatment costs (table 2).
Carrera and Bridges (2006) define medical tourism as
“the organized travel outside one’s natural healthcare
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jurisdiction for the enhancement or restoration of the
individual’s health through medical intervention”, using
but not limited to invasive technology. The authors
define medical tourism as a subset of health tourism,
whose broader definition involves “the organized travel
outside one’s local environment for the maintenance,
enhancement or restoration of the individual’s wellbeing
in mind and body”. Importantly, their definition of med-
ical tourism takes into account the territorially bounded
nature of health systems, where access to healthcare is
often but not always limited to national boundaries [6].
Medical tourism constitutes an individual solution to
what is traditionally considered a public (government)
concern, health for its citizens, who at the micro level
are responding to market incentives by seeking lower
cost and/or high quality care overseas that cannot be
found at home. These tourists may be uninsured or
underinsured. Travelling overseas for medical care has
historical roots, previously limited to elites from devel-
oping countries to developed ones, when health care
was inadequate or unavailable at home. Now however,
the direction of medical travel is changing towards
developing countries [7], and globalization and increas-
ing acceptance of health services as a market commodity
[8] have lead to a new trend; organized medical tourism
for fee paying patients, regardless of citizenship, who
shop for health services overseas using new information
sources, new agents to connect them to providers, and
inexpensive air travel to reach destination medical [9].
The impact of medical tourism on health systems is as
yet unknown due to a dearth of data and empirical ana-
lysis of the phenomenon.
Governments are noticeably playing a strong market-
ing and promotional role in the emerging medical tour-
ism industry. This is a clear trend in Southeast Asia,
especially in Thailand, Singapore and Malaysia, the main
regional hubs for medical tourism, where medical tourist
visas are available and government agencies have been
established with the mandate to increase medical tourist
inflows [10]. Governments in Indonesia, the Philippines
and Vietnam have also expressed interest in promoting
the industry. The potential economic benefits of medical
tourism make it an attractive option for governments.
Medical tourism can contribute to wider economic
development, which is strongly correlated with improved
population health status as a whole, e.g. increased life
expectancy, reduced child mortality rates [11]. Encoura-
ging foreign direct investment in healthcare infrastruc-
ture and medical tourist inflows with correspondent
revenue can create additional resources for investment
in health care [12]. Furthermore, medical tourism may
slow or reverse the outmigration of health workers, par-
ticularly of specialists [13].
However, health systems in some of these countries
face challenges in ensuring basic health service coverage
for their own citizens [3]. Two tier healthcare provision
Table 1 Health systems in comparison [3]
Country Thailand Malaysia Singapore
Organizational
structure
Pockets of excellence in some private
Bangkok hospitals
Growing private health sector with
movement of qualified workforce
Balanced public-private mix,
corporatized public sector
National strategy Regional health hub Industrial strategy to develop tourism Economic growth strategy to develop
biomedical industries
Extensive tourism infrastructure Regional service hub
Medical R&D support
Policy impact Issues of growing inequity and urban-
rural divide
Public-private divide Narrow income gaps of public and
private sectors
Racial inequities between public and private
sectors
Table 2 Export of health services [2,4,5]
Estimated
earnings
No. foreign
patients
Origin of patients
(in order of volume)
Specialty
Thailand
(2006)
Baht 36 billion
(US$ 1.1 billion)
1.4 million Japan, USA, South Asia, UK, Middle East,
ASEAN countries
Cosmetic and sex change surgery
Singapore
(2007)
S$ 1.7 billion
(US$ 1.2 billion)
571 000 Indonesia, Malaysia, Middle East Cardiac and neuro surgery, joint replacements,
liver transplants
Malaysia
(2007)
253.84 million
MYR
(US$78 million)
341 288 Indonesia, Singapore, Japan, India, Europe Cardiac and cosmetic surgery
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has emerged in Malaysia, with private services limited to
those who can afford it and public services for the rest
of the population [14]. Thailand’s public to private
health worker brain drain has strained public health
provision, especially in rural areas [15,16]. Trade in
medical supplies, organs, pharmaceuticals and health
worker migration have dominated policy debates about
the impact on health systems in developing countries,
including concerns about intellectual property rights
and access to affordable drugs, the latest medical tech-
nology, and retaining doctors and nurses within the
public sector and/or within the country’s health system
at all. There are growing concerns about the impact of
medical tourism on health systems, particularly equity of
access for both foreign and local consumers [17].
Inequities at home, either by low quality services and/or
inability to pay, prompt people to seek cheaper and high
quality care treatment overseas. As Blouin (2010) con-
tends, a policy question that remains unanswered is
whether medical tourism can improve the capacity of
poor people in developing countries to access health
services. She calls for the exploration of policy mechan-
isms that mitigate the risks associated with medical
tourism, whilst harnessing the potential benefits, for
local consumers [18].
In the academic literature, conceptual analyses of medi-
cal tourism have emerged from a tourism management
perspective, analysing supply and demand factors [19-22],
and as a node in the trade in health perspective [10,23-26].
Legal literature is beginning to cover patient liability issues
when surgery is carried out overseas [27]. Recent work has
begun to analyse medical tourism and its potential impact
on health systems in specific countries [1,28,29]. Yet not
all health systems functions are analysed in these accounts.
A core concern is whether medical tourism diverts
resources from public components of health systems in
destination countries [30]. Furthermore, conceptual frame-
works in the health systems literature focus on the impact
of targeted, vertical interventions in health systems [31].
But medical tourism is a phenomenon rather than an
intervention; its policy implications have yet to be consid-
ered within the context of a health system.
This paper presents a conceptual framework of medi-
cal tourism and policy implications for health systems
in Southeast Asia, drawing on the cases of Thailand,
Singapore and Malaysia, via an extensive review of the
academic and grey literature, as well as insights from
health consultancies in the public and private sectors
across the region. This framework provides a basis for
more detailed country specific studies on the benefits
and disadvantages of medical tourism, of special rele-
vance for policymakers and industry practitioners in
other Southeast Asian countries with similar health
systems where governments have expressed interest in
facilitating the growth of the medical tourist industry.
Bridging the social science disciplines, the public policy
approach to research is a pragmatic one, with the end
goal of translating research into useful policy recom-
mendations, in this instance those that optimise the
benefits of medical tourism for both foreign and local
consumers and mitigate the risks. Research methodol-
ogy is outlined below, followed by the policy implica-
tions of medical tourism for health systems at their
governance, delivery, financing, human resources and
regulation functions [32,33]. The conclusion empha-
sizes the need for concerted data collection efforts and
identifies variables for further analysis of medical tour-
ism’s potential impact on health systems.
Research methodology
Media reports on the medical tourism industry and parti-
cipation in regional conferences enabled the researchers to
pinpoint Singapore, Thailand and Malaysia as the three
main hubs for medical tourism in Southeast Asia for com-
parative analysis. Broadly, there are four types of compara-
tive health policy analyses. The first constitute descriptive
studies, with no hypothesis or testing of explanations on
why patterns exist, leaving policy explanations implicit for
the reader to gauge. The second include collections of
international case studies with some assessment of perfor-
mance, whilst the third type includes studies employing a
common framework for analysis (e.g. privatization). The
fourth type of cross national studies are those that show a
fundamental theoretical orientation, with a specific theme
or question as a focus of analysis (Marmor et al 2005:
341 - 2) [34]. We decided to undertake this fourth type of
comparative analysis, in order to generate a conceptual
framework that could be usefully employed by policy-
makers to understand the policy implications of medical
tourism on health systems with similar structures. Meth-
ods employed focussed on conceptualising rather than
describing, where one or more new concepts are devel-
oped to explain what is being studied [35]. An inductive,
theory building approach [36] is appropriate to examine
medical tourism where knowledge is far lacking, especially
in relation to health systems.
An initial informal literature scan using the search cri-
teria “medical tourism AND Asia” in google scholar
revealed a lack of data and authoritative sources on medi-
cal tourism, particularly figures for number of patients
and estimated earnings. Academic literature was searched
exhaustively in the PubMed and Social Science Research
Network databases using the search criteria “medical
tourism AND Asia” (92) and “medical travel AND Asia”
(806), generating a range of mostly conceptual research.
Abstracts were scanned for reference to Thailand, Singa-
pore and Malaysia and/or reference to health systems in
general. Additional articles were located using the
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reference list of selected articles. Study selection was not
systematic; no article was omitted but considered in the
context of health systems/medical tourism in Asia (43).
Articles gathered were then categorised according to
content focus (e.g. privatisation of health systems, medi-
cal tourism empirical evidence, health and trade nexus).
Following categorisation, all articles were analysed to
identify medical tourism interaction points across the
health system functions, with new material continually
brought into the analysis. Concurrent to the theory build-
ing process, quantitative data on the nature of health sys-
tems in the three study countries were retrieved from
official country sources and the World Health Organiza-
tion. These data were triangulated with the academic lit-
erature to validate claims made about the nature of
health systems. This data also enabled the researchers to
make systematic comparisons between the three country
health systems. Following this step, grey literature were
searched using the above search criteria in Factiva, a
news item database, to provide examples of recent devel-
opments in the medical tourist industry in the three
study countries. Other grey literature sources included
management consultancy research reports, working
papers on medical tourism, and medical tourism industry
player’s statistics and promotional materials. Subsequent
to analysis and identification of the conceptual frame-
work, potential policy options were outlined based on the
literature and/or innovative examples of comparative
health policy responses in the region. We anticipated that
the different nature of health systems (e.g. mostly public
versus private delivery) would also generate differential
policy implications according to local context. In the
course of our comparative analysis, we found this to be
the case to a large extent; however, medical tourism
poses potential risks and benefits regardless of the cur-
rent nature of a health system. As a phenomenon, it can
fundamentally change the nature of health systems them-
selves without policy intervention (e.g. shift towards a
dominantly private hospital sector). Thus, the policy
implications described are broadly applicable to health
systems in general, but of particular relevance to policy-
makers and industry practitioners in other Southeast
Asian countries where governments have expressed an
interest in developing the medical tourist industry.
Results
Governance in separate domains of trade and health
Medical tourism straddles the policy domains of trade
and health. Its rise is situated within the rapid growth of
trade in health services, driven by increased international
mobility of service providers and patients, advances in
information technologies and communications, and an
expanding private health sector [10]. Trade by definition
is international, but health systems (financing, delivery
and regulation) remain nationally bounded. Additionally,
trade objectives of increased liberalisation, less govern-
ment intervention and economic growth generally do not
emphasize equity, whereas health sector objectives like
universal coverage do. Consequently, actors in the trade
and health policy spheres tend to have conflicting objec-
tives, and trade and health governance processes remain
relatively separate at three levels; the international
(World Trade Organisation (WTO) and World Health
Organisation (WHO)), regional (Association of South
East Asian Nations (ASEAN)) and national (government
ministries). Reconciling the aims of economic growth
with equitable health service provision and access makes
governance of medical tourism within a country’s health
system challenging at best and contradictory at worst.
At the international level, there are clear tensions
between the goals of protecting and promoting health
and generating wealth through trade [23]. Trade and
health policy negotiations occur in isolation, despite the
growing importance of the trade and health nexus at the
global level, e.g. extensive health worker migration and
cross border consumption of health services (medical
tourism) [10,23]. WTO membership requires adherence
to a multitude of legally binding obligations, including
removal of tariff and non tariffs barriers on goods and
services. The WTO’s formal governance architecture is
embodied in its legally binding trade agreements and
compulsory legal dispute mechanism. These legal appara-
tus afford it more compliance clout than the WHO,
which by contrast is an advocacy organization. The
WHO imposes no legal obligations on members, relies
on non binding agreements, and has no compulsory dis-
pute mechanism. Thus enforcement capacity in cases of
non compliance to WHO agreements is limited [23].
Economic growth and trade considerations are likely to
surpass health objectives at the global level when coun-
tries face sanctions or legally punitive measures for non
compliance with trade agreements. Examples of trade
and health policy incoherence include patents on essen-
tial medicines and tobacco promotion in developing
countries, permitted by trade agreements [37].
Whilst most trade in health services takes place outside
the framework of existing trade agreements, whether
bilateral or multilateral [25], trade in health services
including medical tourism is officially provisioned for
under the General Agreement on Trade in Services
(GATS). The four modes of supply include; 1. The cross
border supply of services (remote service provision, e.g.
telemedicine, diagnostics, medical transcriptions), 2.
Consumption of services abroad (medical tourism, medi-
cal and nursing education for overseas students) 3. For-
eign direct investment (e.g. foreign ownership of health
facilities) and 4. Movement of health professionals [7].
Countries can choose to make GATs commitments
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(which legally bind them to open markets under the aus-
pices and protection of the WTO) sectorally or via a spe-
cific mode. In ASEAN, only Cambodia, Malaysia and
Vietnam have made GATs commitments relevant to the
health sector [38]. Medical tourism is becoming bureau-
cratized, formalized and normalized [17] evidenced by
GATs provisions for the health sector. In the context of
increasing cross border trade in health services, govern-
ments have the option to either schedule GATs commit-
ments in health or continue to trade outside of formal
agreements. With rapidly changing domestic and interna-
tional health markets, the latter looks likely, but it is
worth noting that GATS commitments can also limit the
degree to which foreign providers can operate in the
market [39]. In policy terms, this clause can protect
health systems from monopolization by foreign investors
in the health sector.
Regionally, trade also tends to trump health in terms of
policy action. ASEAN is primarily a trade forum, and the
1995 ASEAN Framework on Agreement on Trade in Ser-
vices (AFAS) makes provisions for services liberalisation
between members beyond the WTO GATs. Unlike the
WTO, ASEAN has no legal authority to enforce compli-
ance, but a dispute settlement mechanism was recently
signed. Whilst the health sector is not covered under the
AFAS, it is envisioned that the free flow of all goods, ser-
vices, investments, capital and skilled labour will be
achieved to create an ASEAN Economic Community
(AEC) by 2020 [40,41]. The ASEAN Economic Commu-
nity (AEC) council meets bi annually to work towards
deepening and broadening regional economic integration.
In contrast, the ASEAN Health Minister’s Meeting
(AHMM) is held every two years. Currently, ASEAN
health cooperation is limited to disaster preparedness for
natural disasters and infectious disease outbreaks. Agree-
ments in health are limited to sanitary and phytosanitary
measures, bar a non legally binding Mutual Recognition
Agreement (MRA) on the movement of health profes-
sionals. The ASEAN Work Plan on Health Development
(2010 - 2015) was finalised in July 2010 to cover broader
regional health issues, including non communicable dis-
eases, maternal and child health and primary health care
[42,43]. Despite ASEAN’s regional economic and health
integration, there have been no agreements signed con-
cerning the medical tourism industry. Foreign direct
investment by regional players in neighbouring countries
is accelerating, with private companies like Singapore’s
Parkway Holdings (one of the largest hospital operators
in Asia) and the Raffles medical group acquiring hospitals
in Singapore, Malaysia, Brunei, India and China [26].
Malaysia’s state investment company Khazanah’s $2.6 bil-
lion bid in Parkway Holdings in 2010 gave it a 95% stake
in the company [44]. Foreign investment by both private
and state investment companies implies that significant
profits can be made in the health sector of other coun-
tries, with profits accruing to shareholders overseas and
few benefits for local consumers, unless profits are taxed
and reinvested in the destination health system. The sub-
stantive economic capacity of these regional players
means that health policy aims, like universal access to
healthcare, are likely to come secondary to trade policy
aims, like increasing foreign investment that can be
gained from medical tourism.
Trade and health policy incoherence in promoting both
medical tourism and universal coverage for local consu-
mers at the national level is evident. Whilst several stu-
dies on medical tourism allude to government’s role in
promoting medical tourism [8,16,21], these do not differ-
entiate between the role of different government minis-
tries and their respective policy aims. Trade and tourism
ministries are primarily concerned with increasing eco-
nomic growth and facilitating international trade in the
services sector. In contrast, a health ministry’s aim is to
improve overall population health and ensure equity in
health service access and delivery. Health systems are
also nationally bounded; maximising scarce public
resources for health within given territorial constraints
gives rise to healthcare protectionism by governments,
typified by strict eligibility requirements for access to
state subsidised services by migrants. Whilst expansionist
medical tourism policies had been initiated in trade and
tourism ministries of all three countries, there appears to
be a spill over effect on ministries of health (MOH).
Increasingly, MOH’s are establishing medical tourism
committees and departments, dedicated to the promotion
of their respective countries’ health facilities to other gov-
ernments/foreign patients. For example, Thailand’s medi-
cal hub policy was initiated in 2003 by the government
agency the Thailand Board of Investment, whilst the
Ministries of Commerce, Department of Export Promo-
tion and the MOH in collaboration with private hospitals
are now the main implementers of the policy [15]. Whilst
Malaysia’s national health plan does not mention medical
tourism as a strategic aim [45], the MOH formed an
inter-ministerial committee for the promotion of medical
and health tourism (MNCPHT) in 2003 [28]. Of the
three countries, Singapore’s government agencies have
the most integrated policy stances that strongly support
medical tourism [2], reflective of the country’s prioritisa-
tion of economic growth. Singapore’s Tourism Board, the
Ministry of Trade and Industry’s Economic Development
Board and the MOH have set a target to attract 1 million
foreign patients by 2012 [46], whilst one of the MOH’s
explicit priorities is to “exploit the (country’s) economic
value as a regional medical hub” [47]. In 2004, a multia-
gency government initiative (including the MOH) Singa-
poreMedicine was launched with the aim of developing
Singapore as a medical hub. Whilst trade and tourism
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and health ministry objectives are not easily reconciled,
medical tourism growth provides an opportunity for inter
ministry policy coordination, e.g. via a cross subsidization
mechanism whereby medical tourist revenues are taxed,
providing extra income for public hospitals. In the three
countries, an apparent convergence in trade, tourism and
health ministry priorities is taking place, reflective of
growing acceptance of health as a private good globally.
Improved data collection on medical tourist flows and
health systems use and access by local consumers are
necessary to assess whether policies that promote medi-
cal tourism and universal coverage are reconcilable. Pre-
emptively, government ministries should work towards
more integrated governance of medical tourism, espe-
cially given the highly privatised health system landscape
and existing inequities in health systems use and access
by local consumers, which could be aggravated by foreign
patient inflows.
Delivery in private versus public sector
Medical tourism is driven by the for profit private sector
in health systems. The private sector dominates primary
care provision in Singapore and Malaysia, but is slowly
expanding its role in tertiary hospital care. Private pri-
mary care providers are concentrated in urban areas,
with public primary care providers catering to those in
rural areas, as seen in Thailand and Malaysia [14,48].
Hospital services are dominated by the public sector,
with a 70 - 80% share of beds (table 3) but private hospi-
tal providers are steadily growing. In Thailand, private
hospital numbers have hovered consistently at 30% of
total hospitals between 1994 and 2006 [48]. In Singapore,
private sector hospital growth has risen in proportion
with public sector hospital growth between 1998 and
2008 [49]. Private hospitals are smaller in size and tend
to be located in urban areas, serving middle to high
income patients as well as foreign patients [50]. In gen-
eral, the public private mix of healthcare provision in this
region reflects the country’s level of economic develop-
ment. During economic growth periods, wealthier popu-
lations have emerged with demand for private providers
in response to perceived lower quality public provision.
Consequently the public sector has become more pro
poor as this group cannot afford private care, leading to
the development of a two tier healthcare system seen in
Thailand and Malaysia [14,51]. Public services are gener-
ally perceived to be of low quality or unresponsive in this
region by local consumers [5052]. The steady growth of
private sector hospitals has mirrored the increase in
medical tourism (tables 2 and 3).
The link between a growing private, for profit sector
that caters to medical tourists and access to such services
by local consumers without the ability to pay is elusive.
Private ownership of health facilities means that benefits
accrued (profits from service fees for foreign patients) are
remitted offshore to companies based in different coun-
tries who are investing in private hospital chains across
Southeast Asia. For example, the recent Fortis-Parkway
merger of the second largest Indian healthcare group
with the largest private Singapore-Malaysia group created
the largest hospital chain in Asia. Parkway’s subsequent
take-over bid by Malaysia’s state investment company
Khazanah, means that profits accrued are remitted to
Malaysia for health services rendered in Singapore and
India. Purchase of costly technology that doesn’t have a
wider social benefit for the procedures that medical tour-
ists demand has raised concerns about “crowding out”
local consumption of high technology procedures [12].
Furthermore, government subsidies for private sector
growth, via tax breaks and preferential access to land, is
unlikely to benefit the health system at large nor facilitate
broader public health goals (universal coverage) if private
hospitals cater to larger shares of fee paying, foreign
patients. This can be seen in Malaysia, where tax incen-
tives are available for building hospitals (industry build-
ing allowance), using medical equipment, staff training
and service promotion (deductions on expenses incurred)
[8]. Private sector growth in health is implicitly encour-
aged via these benefits, at the same time as government
construction of new hospitals has stalled due to alleged
insufficient public funds [56].
Medical tourism is emerging in public sector hospitals
at the same time as it is being driven by the private sec-
tor, notably in corporatized (public) hospitals. Corpora-
tization of hospitals in Singapore since 1985 granted
hospitals greater autonomy and exposure to market
Table 3 Public versus private health provision [49,53-55]
Hospitals Beds Beds per 1000 population Primary care clinics
Public (%) Private (%) Public (%) Private (%) Public Private
Thailand 67.9%
(2007)
32.1%
(2006)
69.3%
(2006)
30.7%
(2006)
2.2
(2002)
80.5%
(2007)
19.5%
(2006)
Singapore 63.6%
(2009)
36.4% (2009) 80.6%
(2009)
19.4%
(2009)
3.2
(2007)
1.5%
(2005)
98.5%
(2005)
Malaysia 40.6%
(2008)
59.4%
(2008)
77.9%
(2008)
22.1%
(2008)
1.8
(2007)
32.1%
(2008)
67.9%
(2008)
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competition under government ownership, with the aim
of lowering costs and improving service quality [57]. All
public hospitals in Singapore are Joint Commission
International (JCI) accredited [58]. Given that these hos-
pitals are publicly owned, revenues accruing to medical
tourism are taxable and thus profits can be reinvested
back into the public health system by the government.
In Malaysia and Thailand, some public hospitals are
allowing their surgeons to operate a private wing for
private patients, including medical tourists. This policy
move could incentivise surgeons to treat the additional
fee paying foreign patients over local consumers, when
public health resources are already strained in those
countries.
The majority of medical tourists in Southeast Asia hail
from neighbouring countries, reflecting inequities in ser-
vice provision at home, either via unavailability of quality
services or underinsurance. In Singapore and Malaysia,
most medical tourists are from ASEAN countries, whilst
Thailand’s consumers are often from outside the region,
with the Japanese accounting for the largest share of for-
eign patients (table 2) [50]. Indonesians travel to Singapore
and Malaysia for medical treatment, whilst Cambodians
cross the border to Vietnam for higher quality health ser-
vices. Low quality public and private health provision at
home forces them to leave for overseas treatment. Cost is
a factor, but Malaysian, Singaporean and Thai hospitals
offer specialised services unavailable in other, especially
poorer, ASEAN countries [2,50]. The policy implications
go beyond the potential to crowd out consumption by
locals. As Chee (2010) points out, when middle class fee
paying patients decide to undertake treatment abroad,
their domestic health systems lose out, not only financially
but in terms of the political pressure that these potential
consumers could exert to improve the health system that
poorer consumers rely upon [28]. The possibility to “exit”
low quality health systems gives the middle class little
incentive to exert pressure for quality improvement [59].
Policy options that raise quality standards and minimize
quality differentials, both within and between countries in
Southeast Asia, would benefit both foreign and local con-
sumers. These include public private linkages via profes-
sional exchanges, joint training initiatives, shared use of
facilities between public and private providers to maximise
resource use, telemedicine, and use of complementary/
specialised treatments [1,12].
Healthcare financing and consumerism
Consumer driven healthcare is becoming the normalised
globally and in this region, partly encouraged by govern-
ments and the private sector seeking to shift responsibility
for one’s health to the individual in response to rising
healthcare costs and demand for services. Singapore and
Malaysia exemplify this trend, as public health expenditure
has slowly been declining whilst private health expenditure
has increased [28]. The Thai government spent almost
double the amount on health as a percentage of total gov-
ernment expenditure (14.1%) compared to Singapore
(8.2%) and Malaysia (6.9%) in 2008 [53]. As table 4 shows,
the Thai government contributes the majority of total
health spending (75.1%), in contrast to Malaysia and Sin-
gapore, where private health spending surpasses govern-
ment health spending. Although both Singapore and
Malaysia in theory offer 100% population coverage, high
out of pocket payments (OPPs) suggest effective coverage
is less than this [52]. Both countries are encouraging
greater use of individual financing instruments to pay pro-
viders, in addition to compulsory state insurance schemes
(Medishield in Singapore) or taxation (Malaysia). These
include medical savings accounts (Medisave in Singapore,
Employee Provident Fund Account 2 in Malaysia) [60]
and widespread private insurance. Thailand is the excep-
tion, where the government’s commitment to enrolling
the population in its universal social insurance scheme
means that government investment in health has risen
since 2002 [56,61,62].
The most regressive financing mechanism, out of pocket
payments (OPPs), dominates private health spending in all
three countries. More OPPs for services leads to more
competition in private healthcare markets, as providers are
more likely to compete for patients based on price, espe-
cially given the price transparency made possible by the
internet. Medical tourist payments are dominated by
OPPs, but these payments are becoming more organized
as part of insurance coverage. For example, since March
2010 Singapore’s Medisave can be used for elective hospi-
talizations and day surgeries in hospitals of two partner
providers in Malaysia, Health Management International
and Parkway Holdings [63]. Deloitte’s 2009 medical tour-
ism industry report highlighted four US health insurers
who are piloting health plans that permit reimbursement
of elective procedure overseas in Thailand, India and Mex-
ico [64]. The trend of insurance companies and employers
turning to foreign medical providers to reduce costs looks
set to continue as the medical tourism industry grows [29].
One policy implication of the increase in medical tour-
ists on health financing is that differential pricing for for-
eign patients could drive up costs of services for local
consumers over time. Redistributive financing mechanisms
may offset these increases. Policy options include taxing
medical tourist revenues to be reinvested in the public
health system [12], expanding financing instruments that
do not tie access to ability to pay (taxation, social insur-
ance) and mandating private providers to participate in
schemes that provide coverage to local consumers. Private
hospitals could provide services to a specified percentage
of foreign patients and local consumers enrolled in state
schemes, or provide certain specialist treatment for locals
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(depending on a centre’s area of clinical expertise). The
need for such policies is pressing when, for example, pri-
vate hospitals treating foreign patients in Thailand cur-
rently do not participate in social health insurance
schemes, which covered 98% of the population in 2009
[25,52,65].
Human resources and specialists
Health worker shortages persist to varying degrees in
Southeast Asia, at the same time as demand for health
services from foreign patients is rising. Whilst all three
countries have health worker densities above the WHO
critical threshold of 2.28 health workers per 1000 popula-
tion, all countries face pressures to supply trained health
workers to meet population health needs [66,67]. There
are low doctor-to-patient ratios in Thailand and Malaysia
(table 5), as well as continual outmigration of doctors
from Singapore and Malaysia. Within ASEAN, these two
countries record the highest levels of doctor outmigra-
tion to OECD countries [68]. International outmigration
from Thailand is low, but intra-country migration from
rural to urban areas and maldistribution of health work-
ers is common [15,16]. In response to shortages, Singa-
pore has been able to attract health workers from the
Philippines and Malaysia. In Thailand, health workers
must pass medical exams in Thai, limiting potential for
physician immigration to the country. Whilst the foreign
medical workforce inflow to Malaysia has been substan-
tial, this has been insufficient to offset the outflow of
Malaysian doctors to other countries [25].
Rising demand for health services in the region has
precipitated the growth in private medical and nursing
schools across Southeast Asia and correspondent rise in
trained health workers. Public and private medical
schools in the region are establishing partnerships with
reputable universities overseas. Thailand’s Mahidol uni-
versity nursing department has established links with
nursing schools in Sweden, Canada, Australia, Korea,
the UK and the USA to facilitate student and teaching
exchanges. Singapore’s National University recently
opened a graduate medical school with Duke university
in the USA, and Malaysia’s Sunway university medical
school trains students in partnership with Monash uni-
versity in Australia. Such partnerships facilitate capacity
building in human resources for health, as well as access
to new markets for universities overseas. Importantly,
these partnerships signal quality of human resources,
crucial to the promotion of medical tourism [17].
Developing the medical tourism industry can be seen as
a tactic to reduce international emigration of health work-
ers, particularly of specialists. Anecdotal evidence from
Thailand indicates that medical graduates, having acquired
specialised medical degrees abroad, are finding it lucrative
and more satisfying to stay in their home country [2]. Poli-
ticians in Singapore have reasoned that in order to recruit
and retain specialists in a country with a small local popu-
lation, that the country must attract a high volume of
medical tourists. However, within countries, the growth of
medical tourism may exacerbate public to private sector
brain drain, notably of specialists who provide elective sur-
geries demanded by foreign patients. Whilst the propor-
tion of doctors working in the public sector is higher than
in the private sector in medical tourist countries (table 5),
dual practice, whereby doctors combine salaried, public
sector clinical work with fee for service private clientele
[70], is common amongst specialists in Thailand and
Malaysia. Retaining public sector specialists has become a
challenge with the prospect of higher salaries and lower
workloads in the private sector. Singapore has managed to
maintain competitive public sector salaries, but in
Table 4 Health expenditure [53]
Total health
expenditure as %
of Gross Domestic
Product (2008)
Government
expenditure on health
as % of total
government
expenditure (2008)
Government health
expenditure as % of
total health
expenditure (2008)
Private
expenditure as
a % of total
health
expenditure
(2008)
Out of pocket
expenditure as a
% of private
health expenditure
(2008)
Private prepaid
plans as a % of
private health
expenditure
(2008)
Thailand 4.0% 14.1% 75.1% 24.9% 71.1% 20.9%
Singapore 3.4% 8.2% 35.0% 65.0% 93.9% 2.8%
Malaysia 4.3% 6.9% 44.1% 55.9% 73.2% 14.4%
Table 5 Human resources for health [49,53,69]
Doctors per 1000 population Doctors Nurses per 1000 population Nurses
Public (%) Private (%) Public (%) Private (%)
Thailand 0.4 (2000) 78.4% (2005) 21.6% (2005) 2.8 (2000) 87.8% (2005) 12.2% (2005)
Singapore 1.5 (2003) 54.8% (2009) 45.2% (2009) 4.5 (2003) 68.5% (2009) 31.5% (2009)
Malaysia 0.7 (2002) 60.1% (2008) 39.9% (2008) 1.8 (2002) 71.2% (2008) 28.8% (2008)
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Thailand and Malaysia, with larger public - private pay dis-
crepancies, medical tourism has the potential to further
incentivise specialists to shift to the private sector.
Evidence from Thailand suggests that medical tourism is
not negatively impacting the health system by pulling doc-
tors from rural areas. Rather, specialists from teaching
hospitals in urban areas are shifting to private hospitals
catering to foreign patients [67,71]. All three countries
have a high number of doctors with specialty training e.g.
77.5% in Thailand in 2006, [48]. But these specialists are
concentrated in the private sector; in Malaysia, only 25 -
30% of specialists work in the public sector [72]. Singapore
is the exception, where 65% of specialists are in the public
sector [73]. The type of surgery matters; for local consu-
mers seeking specialist, essential surgery (e.g. cardiac,
transplantation procedures), paying to see a specialist in a
private hospital may be the only option. High quality, spe-
cialised care is typically provided in private hospitals and
can only be afforded by middle to high income patients
[50].
Medical tourism could exacerbate already endemic pub-
lic to private brain drain in the region. A related concern
in Thailand is that medical education is largely publicly
funded; private hospitals do not share the costs of such
education, yet hire from the same pool of graduates as the
public sector [50]. Policy options to mitigate internal brain
drain include instituting capitation payments for health
costs and standard fees for doctors, regardless of whether
a patient is local or foreign. Offering higher salaries in the
public sector and bonding publicly funded graduates are
options for governments (all three countries bond their
graduates for between 3 to 5 years). Dual practice of spe-
cialists could be allowed but regulated, so that specialists
dedicate a specified amount of time to treat local consu-
mers. When public funds are used to train specialists who
then shift to the private sector (potentially to treat medical
tourists), redistributive government regulations like paying
a fee to leave the public sector (Thailand) may plug a
short term financial resource gap, but recruitment and
retention is a persistent problem in this region.
Regulation of quality control and new actors
Private hospitals in the three countries are accredited via
different channels, leading to differing quality standards
between public and private hospitals. Private hospital asso-
ciations encourage industry self regulation, whereas public
hospitals are regulated by the MOH or quasi governmen-
tal bodies. For example, publicly owned corporatized hos-
pitals in Singapore operate with autonomy in a
competitive environment, but government ownership
allows them to shape hospital behaviour without cumber-
some regulation [74].
Joint Commission International (JCI) is the most
established medical tourist industry accreditor
worldwide. Of the three profiled countries, Singapore
has the highest number of JCI accredited providers
(18), followed by Thailand (13) and Malaysia (7) [58].
JCI accreditation is an important quality signal to
attract medical tourists, but this process is voluntary.
The differing quality accreditation channels at the
national (private hospital associations vs. MOH) and
international levels may lead to inequitable quality
standards between the public and private sectors,
whereby private hospital standards surpass those in
public hospitals, reflective of the current situation in
low to middle income countries in Southeast Asia. This
has implications for the quality of care received by
local consumers without the ability to pay for private
services, and the potential divergence of health out-
comes between private fee paying patients (foreign and
local) and those that can’t afford such services. Malay-
sia’s Society for Quality in Health (MSQH), a joint reg-
ulatory body launched by the Ministry of Health,
Association of Private Hospitals of Malaysia and the
Malaysian Medical Association, was recently awarded
international accreditation by the ISQua on par with
JCI. As the MSQH covers both public and private hos-
pitals, this kind of international standard setting for
both sectors could provide a regulatory template for
other countries pursuing medical tourism, in order to
ensure that both local and foreign consumers enjoy
similar quality standards. Policy options include com-
mon standards for public and private providers [1]
regulated by government, as well as compulsory JCI
accreditation for hospitals catering to medical tourists.
New brokers that arise between hospitals and patients
are proliferating rapidly. These agencies are located in
developed and developing countries, connecting prospec-
tive patients to providers via the internet. As yet, the medi-
cal brokerage industry has no codes of conduct, and the
lack of medical training of brokers raises questions about
how these new actors evaluate quality of care when choos-
ing which facilities to promote to prospective patients.
There are also no explicit formal standards when estab-
lishing referral networks, which could be open to abuse, e.
g. financial incentives for brokers from providers to pro-
mote facilities) [17]. Regulating medical tourist brokers
should be a policy priority in both source and destination
countries.
Discussion and directions for future research
Based on the health systems functions of governance,
delivery, financing, human resources and regulation
[32,33], the conceptual framework (Figure 1) aims to
provide a basis for further empirical studies weighing
the benefits and disadvantages of medical tourism for
health systems, of particular relevance to countries in
Southeast Asia.
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The framework facilitated the identification of the
following variables for empirical analysis:
Governance: the number and content of GATs health
sector commitments, the number and size of medical
tourist government committees or agencies, availability
of medical tourist visa.
Delivery: number of hospitals in public and private
sector treating foreign patients, consumption of health
services by domestic and foreign population (hospital
admissions).
Financing: medical tourist revenues, type of medical
tourist payment (service fee or insurance, level of copay-
ment), foreign direct investment in the health sector.
Human resources: doctor and nurse ratios per 1000
population, proportion of specialists in the public and
private sectors, number of specialists treating foreign
patients.
Regulation: number of JCI accredited hospitals, num-
ber of medical tourist visits facilitated by brokers.
At present there is an acute lack of reliable empirical data
concerning medical tourist flows. Most urgently, a universal
definition of who counts as a medical tourist (e.g. per pro-
cedure or per inpatient) should be agreed on, ideally at the
international (WHO) or regional level (amongst Ministries
of Health, Trade, Tourism and private hospital associa-
tions). Variation in definitions and estimates amongst the
three study countries alone are significant. Singapore’s
Tourism Board estimates medical tourist inflows based on
tourist exit interviews with a small sample population,
whilst the Association of Private Hospitals in Malaysia
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Figure 1 Conceptual framework for medical tourism and policy implications for health systems.
Pocock and Phua Globalization and Health 2011, 7:12
http://www.globalizationandhealth.com/content/7/1/12
Page 10 of 12
collects data only from member hospitals and includes all
foreign patients, including foreign residents and those who
happen to require medical care whilst on vacation [28].
Thailand’s Ministry of Commerce collects data on medical
tourist inflows from private hospitals, counting foreign
patients as the APHM does, except that definitions between
hospitals about numbers vary (some count inpatient admis-
sions, others per procedure) [71]. Standardised data collec-
tion will enable researchers to make meaningful cross
country comparisons, as well as carry out detailed country
specific studies to investigate the benefits and disadvantages
of medical tourism’s impact on health systems.
Conclusion
The rise of medical tourism in Thailand, Singapore and
Malaysia and governments’ endorsement of the trend
has raised concerns about its potential impact on health
systems, namely the exacerbation of existing inequitable
resource distribution between the public and private
sectors. Nowhere is this more evident than in Southeast
Asia, where regulation and corrective policy measures
have not kept pace with rapid private sector growth dur-
ing the past few decades. This paper presents a concep-
tual framework (Figure 1) that identifies the policy
implications of medical tourism for health systems, from
a comparative analysis of Thailand, Singapore and
Malaysia. This framework can provide a basis for more
detailed country specific studies, of particular use for
policymakers and industry practitioners in other South-
east Asian countries where governments have expressed
an interest in facilitating the development of the indus-
try. Medical tourism can bring economic benefits to
countries, including additional resources for investment
in healthcare. However, unless properly managed and
regulated on the policy side, the financial benefits of
medical tourism for health systems may come at the
expense of access to and use of health services by local
consumers. Governments and industry players would do
well to remember that health is wealth for both foreign
and local populations.
Acknowledgements
All analysis and opinions expressed in this paper are the authors’ alone. The
authors acknowledge the insights on methodology provided by Wu Xun, as
well as the detailed and helpful comments from Chee Heng Leng on an
earlier version of this draft.
Authors’ contributions
NP conducted the research and wrote the first and final versions of the
draft. KHP commented on the first and subsequent drafts. NP revised the
final manuscript. Both authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 4 October 2010 Accepted: 4 May 2011 Published: 4 May 2011
References
1. Hazarika I: Medical tourism: its potential impact on the health workforce
and health systems in India. Health Policy and Planning 2010, 25:248-251.
2. UNESCAP: Medical travel in Asia and the Pacific: challenges and
opportunities. Thailand, United Nations Economic and Social Commission
for Asia and the Pacific; 2007 [http://www.unescap.org/ESID/hds/lastestadd/
MedicalTourismReport09.pdf], Accessed 29-09-2010.
3. Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R,
Wilopo SA, Lopez AD: Health and health-care systems in southeast Asia:
diversity and transitions. Lancet 2011, 377(9763):429-37.
4. Tourism Malaysia: Media info: Health tourism in Malaysia.
Communications and Publicity Division, Tourism Malaysia; 2008 [http://
www.tourism.gov.my/corporate/images/media/features/Health%20Tourism%
20Oct%202008.pdf], Accessed 29-9-2010.
5. Singapore Medicine: Media Factsheet: Singapore, more than just a world
class healthcare destination. Singapore Medicine; 2010.
6. Carrera P, Bridges J: Health and medical tourism: what they mean and
imply for health care systems. In Health and Ageing. Volume 15. The
Geneva Association; 2006.
7. Carrera P, Bridges J: Globalization and healthcare: understanding health
and medical tourism. Expert Review of Pharmacoeconomics and Outcomes
Research 2006, 6(Suppl 4):447-454.
8. Chee HL: Medical tourism in Malaysia: international movement of
healthcare consumers and the commodification of healthcare. Asia
Research Institute, National University of Singapore, submitted 2007, Accessed
04-03-2011.
9. Whittaker A, Manderson L, Cartwright E: Patients without borders:
understanding medical travel. Medical Anthropology 2010, 29(4):336-343.
10. Smith R, Chanda R, Tangcharoensathien V: Trade in health related
services. Lancet 2009, 373:593-601.
11. Blouin C, Chopra M, Van Der Hoeven R: Trade and social determinants of
health. Lancet 2009, 373:502-507.
12. Chanda R: Trade in health services. Bulletin of the World Health
Organisation 2002, 80:158-163.
13. Hopkins K, Labonte R, Runnels V, Packer C: Medical tourism today: what is
the state of existing nowledge? Journal of Public Health Policy 2010,
31(2):185-198.
14. Chee HL: Ownership, control and contention: challenges for the future
of healthcare in Malaysia. Social Science and Medicine 2008, 66:2145-2156.
15. Pachanee C, Wibulpolprasert S: Incoherent policies on universal coverage
of health insurance and promotion of international trade in health
services in Thailand. Health Policy and Planning 2006, 21(4):310-318.
16. Wibulpolprasert S, Pengpaibon P: Integrated strategies to tackle the
inequitable distribution of doctors in Thailand: four decades of
experience. Human Resources for Health 2003, 1(12) [http://www.human-
resources-health.com/content/1/1/12], Accessed 04-03-2011.
17. Turner L: First world health care at third world prices: globalization,
bioethics and medical tourism. Biosocieties 2007, 2:303-325.
18. Blouin C: Trade in health services: can it improve access to health care
for poor people? Global Social Policy 2010, 10(3):293-295.
19. Connell J: Medical tourism: sea, sun sand and ... surgery. Tourism
Management 2006, 27:1093-1100.
20. Garcia Altes A: The development of health tourism services. Annals of
Tourism Research 2005, 32(1):262-66.
21. Henderson JC: Healthcare tourism in Southeast Asia. Tourism Review
International 2004, 7:111-121.
22. Heung VCS, Kucukusta D, Song H: A conceptual model of medical
tourism: implications for future research. Journal of Travel and Tourism
Marketing 2010, 27:336-251.
23. Fidler DP, Drager N, Lee K: Managing the pursuit of health and wealth:
the key challenges. Lancet 2009, 373:325-31.
24. Lee K, Sridhar D, Patel M: Bridging the divide: global governance of trade
and health. Lancet 2009, 373:416-22.
25. Arunanondchai J, Fink C: Trade in health services in the ASEAN region.
Health Promotion International 2007, 21(Suppl 1):59-66.
26. Diaz Benavides D: Trade policies and export of health services: a
development perspective. Trade in Health Services, Global, Regional and
Country Perspectives Washington DC: Pan American Health Organization,
Program on Public Policy and Health, Division of Health and Human
Development; 2002, 53-69.
Pocock and Phua Globalization and Health 2011, 7:12
http://www.globalizationandhealth.com/content/7/1/12
Page 11 of 12
27. Cohen G: Protecting patients with passports: medical tourism and the
patient protective argument. Harvard Law School Public Law and Legal
Theory Working Paper 2010, 10-08.
28. Chee HL: Medical tourism and the state in Malaysia and Singapore.
Global Social Policy 2010, 10(3):336-357.
29. Forgione D, Smith P: Medical tourism and its impact on the US health
care system. J Health Care Finance 2006, 34(1):27-35.
30. Pennings G: Ethics without boundaries: medical tourism. In Principles of
health care ethics. 2 edition. Edited by: Ashcroft RE, Dawson A, Draper H,
McMillan JR. Chicester: John Wiley and Sons; 2007:505-510.
31. Atun R, De Jongh T, Secci F, Ohiri K, Adeyi O: Integration of targeted
health interventions into health systems: a conceptual framework for
analysis. Health Policy and Planning 2010, 25:104-111.
32. Badara S, Evans T, Dybul M, Atun R, Moatti JP, Nishtar S, Wright A, Celletti F,
Hsu J, Kim JY, Brugha R, Russell S, Etienne C: An assessment of
interactions between global health initiatives and country health
systems. Lancet 2009, 373:2137-69.
33. Hsiao W: What is a health system? Why should we care? Harvard School
of Public Health, working paper 2003.
34. Marmor T, Freeman R, Okma K: Comparative perspectives and policy
learning in the world of health care. Journal of Comparative Policy Analysis
2005, 7(4):331-348.
35. Punch K: Introduction to social research: quantitative and qualitative
approaches. 2 edition. London: Sage; 2005.
36. Glaser BG, Strauss AL: The discovery of Grounded Theory: strategies for
qualitative research New York: Adline Publishing; 1967.
37. Zeigler D: International trade agreements challenge tobacco and alcohol
control policies. Drug and Alcohol Review 2006, 25:567-579.
38. WTO GATs services database. [http://tsdb.wto.org/default.aspx], Accessed
10-2-2011.
39. WTO GATs introduction. [http://www.wto.org/english/tratop_e/serv_e/
gats_factfiction1_e.htm], Accessed 10-2-2011.
40. ASEAN: ASEAN cooperation in trade in services. ASEAN; 2000.
41. Hew D, Soesastro H: Realizing the ASEAN economic community by 2020:
ISEAS and ASEAN - ISIS approaches. ASEAN Economic Bulletin, Institute of
Southeast Asian Studies 2003.
42. ASEAN: ASEAN annual report 2009 - 2010: Bridging markets, connecting
peoples. ASEAN; 2010.
43. ASEAN: Joint statement of the 10th ASEAN health ministers meeting:
“healthy people, healthy ASEAN”. Singapore 2010.
44. Huang R: Khazanah controls 95% of healthcare firm Parkway Holdings.
Channel News Asia; 2010.
45. MOH Malaysia: Strategic plan 2006 - 2010. Ministry of Health Malaysia;
2008.
46. MTI Singapore: Developing Singapore as a compelling hub for healthcare
services in Asia. Health Sector Working Group, Ministry of Trade and
Industry Singapore; 2002.
47. MOH Singapore: Roles and priorities. Ministry of Health Singapore; 2008
[http://www.moh.gov.sg/mohcorp/about.aspx?id=116], Accessed 14-7-2010.
48. MOH Thailand: Thailand health profile report 2005 - 2007. Ministry of
Health Thailand; 2007 [http://www.moph.go.th/ops/thp/index.php?
option=com_content&task=view&id=6&Itemid=2], Accessed 14-7-2010.
49. SingStat: Yearbook of Statistics 2009. Singapore Department of Statistics;
2009.
50. Arunanondchai J, Fink C: Trade in health services in the ASEAN region.
World Bank Policy Research Working Paper 2007, 4147.
51. O’Donnell O, Doorslaer E, Rannan-Eliya RP, Somanathan A, Adhikari SR,
Harbianto D, Garg CC, Hanvoravongchai P, Huq MN, Karan A, Leung GM,
Ng CW, Pande BR, Tin K, Tisayaticom K, Trisnantoro L, Zhang Y, Zhao Y: The
incidence of public spending on healthcare: comparative evidence from
Asia. World Bank Economic Review 2007, 21(1):93-123.
52. Tangcharoensathien V, Patcharanarumol W, Ir P, Aljunid SM, Mukti AG,
Akkhavong K, Banzon E, Huong DB, Thabrany H, Mills A: Health-financing
reforms in southeast Asia: challenges in achieving universal coverage.
Lancet 2011, 377(9768):863-873.
53. WHO: Global Health Observatory. [http://apps.who.int/ghodata/], Accessed
20-01-2011.
54. MOH Malaysia: Health facts 2008. Health Informatics Centre, Planning and
Development Division, Ministry of Health Malaysia; 2009.
55. National Statistical Office of Thailand: The 2007 private hospital survey.
Ministry of Information and Community Technology; 2007.
56. Ramesh M, Xun W: Realigning public and private health care in
Southeast Asia. The Pacific Review 2008, 21(2):171-187.
57. Phua KH: Attacking hospital performance on two fronts: network
corporatization and financing reforms in Singapore. In Innovations in
health service delivery: the corporatization of public hospitals Edited by: Preker
AS, Harding A. Washington DC: Health, Nutrition and Population Series
World Bank; 2003:451-485.
58. Joint Commission International: Accredited organizations. [http://www.
jointcommissioninternational.org/jci-accredited-organizations/], Accessed 20-
01-2011.
59. Hirschman AO: Exit, Voice, and Loyalty: Responses to Decline in Firms,
Organizations, and States Cambridge, MA: Harvard University Press; 1970.
60. Ministry of Finance Malaysia, Employees Provident Fund. [http://www.
kwsp.gov.my/index.php], Accessed 20-01-2011.
61. Phua KH: Health care financing reforms in the Asia-Pacific region. Public
Administration and Policy 2003, 12(1):13-36.
62. Phua KH, Chew AH: Towards a comparative analysis of health system
reforms in the Asia - Pacific region. Asia Pacific Journal of Public Health
2002, 14(1):9-16.
63. MOH Singapore: Medisave for approved overseas hospitalization. MOH
press release; 2010.
64. Deloitte Center for Health Solutions: Medical tourism: update and
implications. Deloitte 2009 [http://www.deloitte.com/us/medicaltourism],
Accessed 20 - 1 - 2011.
65. Hughes D, Leethongdee S: Universal coverage in the land of smiles:
lessons from Thailand’s 30 baht health reforms. Health Affairs 2007,
26:999-1008.
66. WHO: World health report 2006. Geneva, Switzerland; 2006.
67. Kanchanachitra C, Lindelow M, Johnston T, Hanvoravongchai P,
Lorenzo FM, Huong NL, Wilopo SA, De la Rosa JF: Human resources for
health in southeast Asia: shortages, distributional challenges, and
international trade in health services. Lancet 2011, 377(9767):769-781.
68. Bhargava A, Docquier F, Moullan Y: New medical brain drain data set.
2010 [http://perso.uclouvain.be/frederic.docquier/oxlight.htm], Accessed 10-
2-2011.
69. WHO: World health statistics 2009. World Health Organisation; 2009
[http://www.who.int/whosis/whostat/2009/en/index.html], Accessed 29-9-
2010.
70. Ferrinho P, Van Lerberghe WV, Fronteira I, Hipolito F, Biscaia A: Dual
practice in the health sector: a review of the evidence. Human Resources
for Health 2004, 2:14.
71. Phyu YM, Chotbenjakul W: Medical tourism in Thailand and its impact on
the internal brain drain of doctors. Submitted masters thesis National
University of Singapore, Lee Kuan Yew School of Public Policy; 2010.
72. Quek D: The Malaysian healthcare system: a review. Intensive workshop on
health systems in transition: 29 - 30 April 2009; Kuala Lumpur University of
Malaya; 2009.
73. MOH Singapore: Health facts. Ministry of Health Singapore; 2008 [http://
www.moh.gov.sg/mohcorp/statistics.aspx?id=5966], Accessed 14-7-2010.
74. Ramesh M: Autonomy and control in public hospital reforms in
Singapore. American Review of Public Administration 2008, 38(1):62-79.
doi:10.1186/1744-8603-7-12
Cite this article as: Pocock and Phua: Medical tourism and policy
implications for health systems: a conceptual framework from a
comparative study of Thailand, Singapore and Malaysia. Globalization
and Health 2011 7:12.
Pocock and Phua Globalization and Health 2011, 7:12
http://www.globalizationandhealth.com/content/7/1/12
Page 12 of 12
